Clarity Pharma are excited to announce achieving number 13 in Alantra’s annual ranking of the fastest growing private pharma companies in the UK.
The Pharmaceutical industry, like many others, has been hit hard by the Coronavirus pandemic, however Clarity have responded with resilience, adaptability and, most notably innovation – earning them a place in the Alantra Pharma Fast 50.
- Clarity Pharma
Pharmaceutical sale and distribution
Revenue (m): 89.9
2 Year CAGR: 41%
Main Category: Develop, Wholesale and Supply
In the fifth edition of the awards, the 2021 Alantra Pharma Fast 50 ranking provides intriguing insight into swift evolution of both the entire sector and Clarity Pharma as an individual business.
The industry’s growth is clear to see. In the first Alantra Pharma Fast 50, the constituent companies’ combined revenues totalled £2.3 billion; in 2021, this figure has risen to £3.1 billion – a near 35% jump.
There has never been more emphasis and public pressure around delivering effective drugs to patients than over the last 12 months. The businesses in the Pharma Fast 50 are experts in each element of delivery, from research to ensuring ease of movement of vital medicines across borders. more public attention on what it takes to deliver an effective drug to patients than over the last 12 months. The businesses in the Pharma Fast 50 touch on every element of that – from early-stage research right through to ensuring vital medicines continue to flow across borders, with Clarity being no exception. Long may it continue.
For more information about pharmaceutical distribution in the UK, get in touch with a member of our expert team, today.